Orbits Oncology ^Company

Orbits Oncology develops an AI-powered software platform that transforms patient tumor data into digital insights for cancer research. The platform focuses on organoid analysis, enabling researchers to gain insights into treatment-resistant and invasive subclones in cancers like pancreatic cancer. The software employs computer vision to track cells without dyes, making it adaptable for various cancer models.